UNSPSC 51422103: Clocortolone

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N8ZUB7XE0H. European Medicines Agency schedules Clocortolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06686MIG. Clocortolone generally arises in the molecular formula C22H28CLFO4.

UNSPSC 51422103 Clocortolone is a Commodity code nominally designating a topical corticosteroid pharmaceutical, but the recent state and local procurement activity tagged under this code shows a clear mismatch: Seminole County, Florida solicited Naloxone and Safe Drug Deactivation Systems—emergency opioid-reversal medication and hazardous-waste disposal equipment—not clocortolone. The code's nominal scope does not align with what state and local governments are actually buying under it based on available recent opportunities. Issuing bodies purchasing under this code appear limited to county-level health and community service agencies.

Seminole County, Florida represents the only recent activity in the record. The county issued IFB 60459723LAS on June 30, 2026, for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023. Vendors were required to provide unit costs, maintain workers' compensation and general liability insurance, comply with E-Verify and drug-free workplace certification, and include all shipping and delivery costs in their proposals. The contract included a two-year initial term with a one-year renewal option and a three-month probationary period allowing termination at will. The solicitation indicated potential FEMA funding and subject vendors to federal compliance requirements. Given the sparse recent-opportunity record and the code-scope mismatch, this code shows minimal relevant activity for business development targeting state and local pharmaceutical procurement.